1. National adverse drug reaction monitoring annual report. China: National Medical Products Administration. 2020; https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/fgwj/gzwj/gzwjyp/20210325170127199.html.
2. Guideline for basic intravenous infusion assessment in clinical use. China Pharmaceutical Packaging Association. 2018; https://cnppa.org/index.php/Home/Bz/show_2019/id/941.html.
3. United States Pharmacopeia 43 and National Formulary 38. 2020 ed. The United States Pharmacopeial Convention; 2020.
4. Determination of insoluble particles in injection and its effect on microcirculation function;Huihui L;China Pharm,2015
5. Effect of small-sized insoluble particles on inflammation-related indexes in injection;Jianghui Q;China J Pharm Econ,2016